Hikaru Hori Selected Research

Polypharmacy

3/2022	The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
9/2021	Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
12/2013	Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.
6/2012	Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hikaru Hori Research Topics

Disease

36	Schizophrenia (Dementia Praecox) 10/2022 - 01/2007
29	Major Depressive Disorder (Major Depressive Disorders) 05/2022 - 10/2007
5	Treatment-Resistant Depressive Disorder 04/2012 - 07/2008
4	Cognitive Dysfunction 01/2018 - 12/2009
3	Hyperprolactinemia 02/2019 - 02/2013
3	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 10/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2013 - 03/2010
3	Depressive Disorder (Melancholia) 11/2010 - 01/2009
2	Treatment-Resistant Schizophrenia 10/2022 - 01/2022
2	Necrosis 03/2022 - 01/2017
2	Mental Disorders (Mental Disorder) 01/2022 - 03/2010
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 10/2006
2	Neurobehavioral Manifestations 01/2020 - 01/2014
2	Mood Disorders (Mood Disorder) 10/2019 - 11/2010
2	Meige Syndrome 09/2016 - 01/2011
2	Tobacco Use Disorder (Nicotine Dependence) 04/2012 - 04/2010
2	Occupational Stress 04/2011 - 04/2008
2	Anxiety Disorders (Anxiety Disorder) 08/2010 - 01/2009
1	Hyperthyroidism 01/2022
1	Inflammation (Inflammations) 12/2021
1	COVID-19 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Tardive Dyskinesia 01/2020
1	Obesity 01/2020
1	Delirium 01/2020
1	Dystonia (Limb Dystonia) 01/2020
1	Basal Ganglia Diseases (Basal Ganglia Disease) 02/2019
1	Psychomotor Agitation (Akathisia) 02/2019
1	Neurodevelopmental Disorders 01/2018
1	Photophobia (Light Sensitivity) 09/2016
1	Blepharospasm 09/2016
1	Dysarthria (Spastic Dysarthria) 09/2016
1	Pain (Aches) 09/2016
1	Trismus (Lockjaw) 09/2016
1	Muscle Rigidity 01/2016
1	Galactorrhea 01/2016
1	Hiccup (Hiccups) 05/2014
1	Paranoid Schizophrenia (Delusional Disorder) 05/2014
1	Gambling (Pathological Gambling) 01/2014
1	Substance-Related Disorders (Drug Abuse) 01/2014
1	Personality Disorders (Personality Disorder) 01/2014

Drug/Important Bio-Agent (IBA)

28	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 10/2006
17	Antipsychotic Agents (Antipsychotics)IBA 10/2022 - 10/2006
11	Antidepressive Agents (Antidepressants)IBA 01/2022 - 07/2009
11	Aripiprazole (Abilify)FDA Link 11/2021 - 01/2009
11	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2021 - 10/2006
11	MethoxyhydroxyphenylglycolIBA 03/2017 - 06/2007
10	CatecholaminesIBA 03/2017 - 10/2006
9	Olanzapine (Zyprexa)FDA Link 11/2021 - 01/2007
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2008
7	Homovanillic AcidIBA 03/2017 - 12/2009
7	Paroxetine (Paxil)FDA LinkGeneric 01/2016 - 10/2007
6	Interleukin-6 (Interleukin 6)IBA 03/2022 - 06/2009
6	Pharmaceutical PreparationsIBA 11/2021 - 08/2007
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2014 - 01/2009
4	Fluvoxamine (Luvox)FDA LinkGeneric 01/2017 - 08/2007
3	Clozapine (Clozaril)FDA LinkGeneric 10/2022 - 11/2021
3	CytokinesIBA 03/2022 - 04/2008
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 01/2018
3	Paliperidone Palmitate FDA Link 11/2021 - 09/2016
3	blonanserinIBA 09/2021 - 01/2014
3	Sertraline (Zoloft)FDA LinkGeneric 12/2012 - 12/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011 - 11/2009
2	InterleukinsIBA 03/2022 - 09/2013
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 09/2021
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022 - 09/2021
2	LithiumIBA 01/2022 - 06/2014
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2015 - 04/2014
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2015 - 01/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2014 - 04/2012
2	Serotonin and Noradrenaline Reuptake InhibitorsIBA 04/2012 - 06/2009
2	gamma-Aminobutyric Acid (GABA)IBA 12/2010 - 12/2009
1	asenapine FDA Link 05/2022
1	Escitalopram FDA Link 05/2022
1	EnzymesIBA 03/2022
1	Interleukin-2 (IL2)IBA 03/2022
1	Interleukin-8 (Interleukin 8)IBA 03/2022
1	Interleukin-4 (Interleukin 4)IBA 03/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2022
1	ImmunosorbentsIBA 03/2022
1	N-acetyltryptophanamide (NATA)IBA 03/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Celecoxib (Celebrex)FDA Link 12/2021
1	Quetiapine Fumarate (Seroquel)FDA Link 09/2021
1	Doxazosin (Cardura)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 01/2020
1	Trazodone (Trittico)FDA LinkGeneric 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Viral ProteinsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	AntiemeticsIBA 01/2016
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2016
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2016
1	valylvaline (Val-Val)IBA 01/2015
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2014

Therapy/Procedure

4	Polypharmacy 03/2022 - 06/2012
4	Therapeutics 01/2020 - 10/2006
1	Drug Therapy (Chemotherapy) 03/2022